EP1496923A4 - Immunotherapie du cancer - Google Patents
Immunotherapie du cancerInfo
- Publication number
- EP1496923A4 EP1496923A4 EP02723576A EP02723576A EP1496923A4 EP 1496923 A4 EP1496923 A4 EP 1496923A4 EP 02723576 A EP02723576 A EP 02723576A EP 02723576 A EP02723576 A EP 02723576A EP 1496923 A4 EP1496923 A4 EP 1496923A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cancer immunotherapy
- immunotherapy
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002619 cancer immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001116—Receptors for cytokines
- A61K39/001119—Receptors for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/008983 WO2003092717A1 (fr) | 2002-03-22 | 2002-03-22 | Immunotherapie du cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1496923A1 EP1496923A1 (fr) | 2005-01-19 |
EP1496923A4 true EP1496923A4 (fr) | 2005-10-19 |
Family
ID=29398905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02723576A Withdrawn EP1496923A4 (fr) | 2002-03-22 | 2002-03-22 | Immunotherapie du cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1496923A4 (fr) |
JP (1) | JP2005526842A (fr) |
AU (1) | AU2002254348B2 (fr) |
CA (1) | CA2480008C (fr) |
WO (1) | WO2003092717A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060228369A1 (en) * | 2005-04-11 | 2006-10-12 | Program For Appropriate Technology In Health | Stabilization and preservation of temperature-sensitive vaccines |
EP2084267B1 (fr) | 2006-09-26 | 2018-04-11 | Cedars-Sinai Medical Center | Vaccins comprenant des antigenes de cellules souches cancereuses et procedes |
US8871211B2 (en) | 2006-09-28 | 2014-10-28 | Cedars-Sinai Medical Center | Cancer vaccines and vaccination methods |
CN103223165B (zh) * | 2007-08-24 | 2015-02-11 | 学校法人庆应义塾 | 肿瘤细胞所导致的免疫抑制的解除剂及使用该解除剂的抗肿瘤剂 |
US9068020B2 (en) | 2008-09-02 | 2015-06-30 | Cedars-Sinai Medical Center | CD133 epitopes |
ES2662333T3 (es) | 2013-02-14 | 2018-04-06 | Immunocellular Therapeutics Ltd. | Vacunas contra el cáncer y métodos de vacunación |
CN117801069A (zh) * | 2016-10-07 | 2024-04-02 | 恩特罗姆公司 | 用于癌症疗法的免疫原性化合物 |
EP3522917A2 (fr) | 2016-10-07 | 2019-08-14 | Enterome S.A. | Variants de séquence de microbiote d'épitopes antigéniques associés à une tumeur |
IL296165B2 (en) | 2016-10-07 | 2023-10-01 | Enterome S A | Immunogenic compounds for cancer treatment |
EP3480212B1 (fr) * | 2017-11-03 | 2023-09-27 | Consejo Superior De Investigaciones Científicas | Peptide il13ralpha2 et ses utilisations |
CN115427455A (zh) * | 2020-05-15 | 2022-12-02 | 埃利塞拉疗法公司 | 抗IL13Rα2抗体、其抗原结合片段和用途 |
GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001058479A1 (fr) * | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Utilisation du recepteur de l'interleukine 13, sous-unite alpha 2, dans l'immunotherapie |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614191A (en) * | 1995-03-15 | 1997-03-25 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
-
2002
- 2002-03-22 CA CA2480008A patent/CA2480008C/fr not_active Expired - Fee Related
- 2002-03-22 WO PCT/US2002/008983 patent/WO2003092717A1/fr active Application Filing
- 2002-03-22 JP JP2004500900A patent/JP2005526842A/ja active Pending
- 2002-03-22 EP EP02723576A patent/EP1496923A4/fr not_active Withdrawn
- 2002-03-22 AU AU2002254348A patent/AU2002254348B2/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001058479A1 (fr) * | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Utilisation du recepteur de l'interleukine 13, sous-unite alpha 2, dans l'immunotherapie |
Also Published As
Publication number | Publication date |
---|---|
CA2480008C (fr) | 2015-10-06 |
EP1496923A1 (fr) | 2005-01-19 |
CA2480008A1 (fr) | 2003-11-13 |
AU2002254348B2 (en) | 2007-12-06 |
AU2002254348A1 (en) | 2003-11-17 |
JP2005526842A (ja) | 2005-09-08 |
WO2003092717A1 (fr) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2391392B (en) | Co-located atennas | |
IL166084A0 (en) | Novel benzodioxoles | |
PL371678A1 (en) | Novel pyridin- and pyrimidin-derivatives | |
PL373598A1 (en) | Novel benzonaphthyridines | |
EP1482970A4 (fr) | Therapie anticancereuse | |
ZA200408427B (en) | Adjuvant enhanced immunotherapy | |
GB0228900D0 (en) | Cancer Immunotherapy | |
EP1599572A4 (fr) | Compositions et methodes pour immunotherapie anticancereuse | |
IL163529A0 (en) | Novel spinosyn-producing polyketidesynthases | |
GB0207362D0 (en) | Chemotherapy | |
EP1496923A4 (fr) | Immunotherapie du cancer | |
GB0208516D0 (en) | Chemotherapy | |
AU2003264488A1 (en) | Immunotherapeutic for cancer | |
GB0223696D0 (en) | Improved immunotherapy | |
GB0220658D0 (en) | Immunotherapy | |
GB0225750D0 (en) | Wiffs away | |
GB0226595D0 (en) | Cancer therapy determination | |
EP1587405A4 (fr) | Nouvelles compositions et procedes de traitement du cancer | |
GB0200110D0 (en) | Cancer detection | |
GB0229743D0 (en) | Novel benzoxazocines | |
GB0218725D0 (en) | Cancer related methods | |
GB2383538B (en) | Cancer treatment | |
GB2375065B (en) | Sharpening means | |
GB0215011D0 (en) | Easy squeezy | |
GB0213950D0 (en) | Bannistair slide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041019 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050905 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 35/00 B Ipc: 7C 07K 7/00 B Ipc: 7C 07K 4/00 B Ipc: 7C 07K 2/00 B Ipc: 7C 07K 1/00 B Ipc: 7C 07K 17/00 B Ipc: 7C 07K 16/00 B Ipc: 7C 07K 14/00 B Ipc: 7A 01K 43/04 B Ipc: 7A 61K 31/70 B Ipc: 7A 61K 39/00 B Ipc: 7A 61K 38/00 A |
|
17Q | First examination report despatched |
Effective date: 20060424 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20071204 |